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marine myxobacterium Haliangium ochraceum. A further investigation of the extract of this microorganism has resulted in the isolation of haliangicin as well as its geometrical isomers. The configuration of the epoxide in haliangicin, which was unknown previously, was determined in this study. The planar structures with partial stereochemistry of these isomers were elucidated by spectroscopic analyses. The major isomer, cis-haliangicin, is a cis isomer of the epoxide portion of haliangicin. Haliangicins B-D are geometrical isomers of the polyene moiety, and present as an inseparable mixture of cis and trans epoxide isomers. Their antifungal activities were also evaluated in comparison with haliangicin. Myxobacteria is a cis isomer about the epoxide moiety of 1, and haliangicins B-D (3) (4) (5) are geometrical isomers of the polyene moiety, as well as appear to be mixtures of cistrans isomers of the epoxide moiety ( Fig. 1 ). This paper reports the isolation and structural elucidation of these haliangicin isomers as well as their antifungal activity.
Isolation
The marine myxobacterium Haliangium ochraceum AJ 13395 was used as a haliangicin-producer throughout this study. Although it had been tentatively named H. luteum in the previous papers,8,9) the new species name, H. ochraceum, was recently proposed for the strain with its detailed taxonomic description.10) The marine culture medium containing 2% NaCl. The culture broths (total 9liters) were centrifuged to collect the bacterial cells and an adsorbent resin (productivity enhancer), which were extracted with acetone. The acetone extract was chromatographed on silica gel. The haliangicin-containing fraction was applied to a second silica gel chromatography followed by preparative HPLC to obtain haliangicin (1), haliangicin B (3), haliangicin C (4), and haliangicin D (5) as mixtures of trans-and cis-epoxy isomers in the ratio of 2:1 (Fig. 2) . Since the samples were quite susceptible to decomposition through oxidation in air and light at room temperature, they were handled in dim light and stored in was further subjected to recycle HPLC to obtain pure haliangicin (1) and cis-haliangicin (2) . Although haliangicins B (3), C (4) and D (5) contained their cisepoxy isomers as the minor component (2:1 ratio), we did not succeed in the purification of these isomers.
The antifungal activity of the haliangicins against the phytopathogenic fungus Phytophthora capsici was evaluated by using a paper disc assay method. The minimum doses applied on a paper disc to inhibit the fungus growth in this assay were as follows: 1 (8ng/disc), 2 (8ng/disc), 3 (40ng/disc), 4 (40ng/disc), and 5 cystothiazole A,11) was used as a positive control (200ng/disc).
Structural Elucidation
All the spectroscopic data for haliangicin (1) and H14/12-Me, suggesting a traps stereochemistry of the epoxy moiety ( Fig. 3 and Table 4 ).
The relative stereochemistry of the epoxide in 1, though not stated clearly in the previous report,9) has been determined for the first time in the present study. Table 4 ). The NMR data for cis-haliangicin (2) are summarized in the epoxy cis-isomer of 1, that is, cis-haliangicin, though the relative stereochemistry between the epoxide (C12-C13) and C10 is still unknown.
The structural analysis of haliangicin B (3) was performed as a mixture of two isomers. A thorough analysis of the 2D NMR data for this mixture enabled us to assign all the NMR signals to each of the isomers (Tables 2   and 3 ). The same NOE correlations were observed for the epoxide moiety between 1 and 3 and between 2 and the isomer of 3 (Fig. 3) . On the other hand, a strong NOE correlation between H2 and H5 in the tetraene moiety (Table 4) suggested 2Z configuration for both 3 and its isomer, unlike the 2E configuration for 1 and 2. The other olefins in the tetraene moiety had the same configuration as 1 and 2. Thus, haliangicin B (3) is the 2Z isomer of 1 and the coexistent isomer is the 2Z isomer of 2, that is, cishaliangicin B (cis-3).
Haliangicin C (4) showed the same NOE correlations as those of 1 except for the strong NOE correlations of H5/4-OMe (Table 4) , suggesting 4E geometry. The concomitant minor isomer of 4 showed the same NOE correlations as those of 4 at the tetraene portion (Table 4) , while different NOE correlations were observed for the epoxide moiety, as in the case of 3 and cis-3 (Fig. 3) . Thus, haliangicin (4) is the 4E isomer of 1 and the concomitant isomer is the 4E isomer of 2, namely, cis-haliangicin C (cis-4).
In a similar way, the examination of the NOE correlations (Table 4 , Fig. 3 ) revealed that haliangicin D (5) was the 4E,6E isomer of 1 and that the concomitant minor isomer was cis-haliangicin D (cis-5). 
Discussion
Haliangicin (1) is the first antibiotic isolated from a marine myxobacterium.8,9) Until this discovery, all the myxobacterial antibiotics had originated from terrestrial myxobacteria. Haliangicin (1) inhibits the growth of a variety of fungi but is inactive against bacteria. It interfered with the electron flow within the cytochrome b-c1 segment in the mitochondrial respiratory chains.8) While exploring further antifungal substances from the haliangicinproducing myxobacterium H. ochraceum, we have been able to isolate several isomers of haliangicin (1) and have determined their structures. Haliangicin (1) and its isomers methoxyacrylate moiety, which exhibit antifungal activity.8)
To the best of our knowledge, all the antibiotics possessing cystothiazoles,11,12) myxothiazols,13) and melithiazols.14,15) It is interesting to note that one of our isolates, haliangicin B class of antibiotics. Haliangicin (1) and its cis-isomer (2) show an almost identical activity against the fungus P. capsici. This observation indicates that the relative stereochemistry of the substituents on the epoxide ring, IR spectra were recorded on a JASCO FT/IR-7000S spectrometer. UV spectra were recorded on a JASCO Ubest-50 UV/VIS spectrophotometer. NMR spectra were recorded on a Bruker ARX 400 (400MHz) or a Bruker ARX 600 (600MHz) spectrometer. NMR chemical shifts (CDCl3) for 13C. Mass spectra were recorded on an Applied Biosystems Mariner Biospectrometry Workstation in the positive ESI mode. Polypropylene glycol (PPG) was used as an internal standard for high-resolution analysis.
Isolation
The production culture of the myxobacterium H. ochraceum AJ 13395 was performed under the conditions reported previously.8) The bacterial cells and the adsorption resin SP 207 (Nippon Rensui) was separated from a culture broth (6liters) by centrifugation and extracted with acetone (600ml) at room temperature for 3days (one day should be sufficient). After filtration the filtrate was concentrated to obtain an oily crude sample (590mg). TLC analysis (hexane/EtOAc 4:1) of the crude sample showed the major spot of haliangicins at Rf=0.42. The crude oil was chromatographed on silica gel (35g) with 40ml of benzene, 40ml each of 1%, 2%, 4%, 10%, 20%, 50% of ethyl acetate in benzene, 40ml ethyl acetate, and then 40ml of methanol as successive eluants. The haliangicincontaining fraction (138.7mg) was combined with a second haliangicin-containing fraction (77.8mg) obtained similarly from another culture broth (3liters) and was applied to silica gel (10g) column chromatography with hexane/ EtOAc 4:1 as an eluant to obtain a yellowish orange oil (184.7mg). The oily material was then applied to Nomura Chemical Ltd.; UV at 260nm, 60% CH3CN, 9ml/minute] to obtain haliangicin D (5) (0.4mg, Rt=40.2 minutes), haliangicin C (4) (1.6mg, Rt=47.9minutes), haliangicin (1) (65.7mg, Rt=54.2minutes), and haliangicin B (3) (2.3mg, Rt=84.9minutes) as mixtures containing their corresponding cis-isomers, all as light yellow oils (Fig. 2) . The mixture of 1 and the cis-isomer 2 was further subjected to recycle HPLC (Fig. 2) [Develosil ODS-5 or 7-recycles for two injections] to obtain pure haliangicin (1) (36.5mg) and cis-haliangicin (2) Tables 2 , 3 and 4, respectively.
Assay Method
The antifungal activity of the haliangicins was evaluated by a paper disc assay using the phytopathogenic fungus Phytophthora capsici. Since this filamentous fungus rarely produces spores, the activity was evaluated not by MIC but by the observation of aversion to a paper disc impregnated with a test sample. A piece of agar, 5mm in diameter, containing mycelia of P. capsici previously grown on a synthetic agar medium was placed onto the center of a plate (9cm in diameter) of the same agar medium (1liter medium containing: sucrose 10g, monosodium glutamate CaCl2 0.1g, agar 10g, thiamine hydrochloride 1mg, 2days in the dark, the colony grew to a size of about 3-4cm in diameter. Each paper disc (8mm in diameter), which was impregnated with an EtOAc solution of a known amount of a sample and dried in vacuo, was placed one cm away from the edge of the colony. After incubation under the same conditions for an additional 29 hours when the edge of the colony reached the edge of the paper disc of the control, the distance between the edge of the colony and the paper disc was measured. The control disc was made by in vacuo drying of an EtOAc-containing paper disc.
